Article

A recombinant ‘ACE2 Triple Decoy’ that traps and neutralizes SARS-CoV-2 shows enhanced affinity for highly transmissible SARS-CoV-2 variants

2021-03-09

Abstract excerpt

<h4>ABSTRACT</h4> The highly-transmissible SARS-CoV-2 variants now replacing the first wave strain pose an increased threat to human health by their ability, in some instances, to escape existing humoral protection conferred by previous infection, neutralizing antibodies, and possibly vaccination. Thus, other therapeutic options are necessary. One such therapeutic option that leverages SARS-CoV-2 initiation of in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: eba5533e-1522-5703-a6fc-6e76e5fe20f9
DOI: 10.1101/2021.03.09.434641

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A recombinant ‘ACE2 Triple Decoy’ that traps and neutralizes SARS-CoV-2 shows enhanced affinity for highly transmissible SARS-CoV-2 variantsDOI 10.1101/2021.03.09.434641Read

An ACE2 Triple Decoy that neutralizes SARS-CoV-2 shows enhanced affinity for virus variants.Semantic proximity Read

ACE2-based decoy receptors for SARS coronavirus 2.Semantic proximity Read

A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency.Semantic proximity Read

S19W, T27W, and N330Y mutations in ACE2 enhance SARS-CoV-2 S-RBD binding toward both wild-type and antibody-resistant viruses and its molecular basisSemantic proximity Read

Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants.Semantic proximity Read

Characterisation of a novel ACE2-based therapeutic with enhanced rather than reduced activity against SARS-CoV2 variantsSemantic proximity Read

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2Semantic proximity Read

Computational and Experimental Identification of Potential Neutralizing Peptides Derived from Human ACE2 Against SARS-CoV-2 InfectionSemantic proximity Read

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2.Semantic proximity Read

An engineered decoy receptor for SARS-CoV-2 broadly binds protein S sequence variantsSemantic proximity Read

Engineered ACE2 receptor traps potently neutralize SARS-CoV-2.Semantic proximity Read

High affinity modified ACE2 receptors protect from SARS-CoV-2 infection in hamstersSemantic proximity Read